Jade Biosciences JBIO
NASDAQ JBIO
$14.98 -0.15 (-0.99%)
As of: Oct 22, 2026 · 11:33 AM EDT

Jade Biosciences (JBIO) Long-Term Debt Issuances (2024)

Updated

Jade Biosciences (JBIO) recorded Long-Term Debt Issuances of $95 million in FY2024.

Analysis

Jade Biosciences (JBIO) Long-Term Debt Issuances (2024) Analysis & Trends

  • Annual Long-Term Debt Issuances has a four-year compound annual growth rate of 148.3% (FY2020 to FY2024).
  • The FY2024 figure is the lowest annual Long-Term Debt Issuances since FY2020.
  • Per Business Quant data, JBIO's Long-Term Debt Issuances was $2.5 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,176.80 Bn 1,145.39 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 639.81 Bn 558.34 Bn 17.26 Bn -
3 AbbVie 503.28 Bn 476.39 Bn 12.70 Bn -
4 Merck 376.70 Bn 331.08 Bn 12.21 Bn -
5 Novartis Ag 303.61 Bn 267.60 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 268.37 Bn 242.05 Bn 12.86 Bn -
7 Amgen 242.34 Bn 197.74 Bn 7.24 Bn -
8 Gilead Sciences 193.58 Bn 167.78 Bn 6.22 Bn -
9 Pfizer 172.88 Bn 119.53 Bn 10.94 Bn -
10 Jade Biosciences 917.06 Mn -390.57 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 95.00 Mn
API Access

Jade Biosciences Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=JBIO&period=max&api_key=YOUR_API_KEY